(Watch the Video below to hear about the results of lobbying Politicians. Stay tuned to "The Natto Perspective")
We need to pave the way for the production and
financement of the KIN Intravenous Solution (cloned white blood cells & glucose). The government
needs to provide funding for the public education and actual production of the KIN IV Solution.
Sources for Private financing:
Pharmaceutical industry : New
antibiotics can be derived from the flooding of artificial white blood cells into the system of the sickest people
on earth.
Alcohol & Tobacco Industry: The entire
industry from the farms to the distribution sites can be salvaged. Jobs are at risk!!!!!
Sources for Govt. Financing & International Finance Corporation World Bank Group:
Cutting edge stuff that
is selling well around the World. I have contacted Universities, Scientists, the media, etc. This is important
work because we can speed up the rate of new antibiotics.
Read slowly:
The (Naive or Neutral) white blood cell naturally creates
an antibody to defeat any given virus.
Hospitals take samples of blood to collect the antibodies.
The antibodies (Carbon, Sulphur, Oxygen, Nitrogen,
Hydrogen) are a protein, which means they are a combination of atoms.
The antibodies that defeat the viruses get synthesized
into antibiotics.
When I researched this information I
was surprised that no one was writing about cloning white blood cells. Its the obvious constraint
for new antibiotics. I am trying to market my research to Wallsteet, the Media, Medical Universities,
Genetists, Promotional Companies, etc.
So far The KIN Consortium
has gained the recognition and support of the NIH (The National Institute of Health), The Govt. of Belgium, Scientists around
the world. We are trying to use the contacts of The Chairman (a seasoned wallstreet broker) to raise finance for
the promotion of the medical concept of cloning white blood cells, the textbook, and soon the cloning equipt. This is
huge!!
Signed,
/s/
Khalid "Kal" I. Natto The Chairman of the Board The KIN Consortium Email: Kalnatto2000@yahoo.com
The Chairman of the Board of the KIN
Consulting & Research Services, has decided to share some of their library resources to enhance competition
in the production of the KIN IV Solution (Glucose + Cloned Lymphocytes). He has sent a copy of
this list of DNA Libraries to over 200 Biotechnology Companies around the world, in an effort to promote the medical concept
of cloning lymphocytes. The promotional campaign was then followed up with contacts with financial institutions
like Merrill Lynch, Morgan Stanley, The World Bank, etc. After contacting
the financial institutions the promotional campaign covered The World Health Organization, Swiss
Red Crossand The Red Crescent, West African Parmaceutical Companies, the governments of Japan,
Canada, Egypt, Kingdom of Saudi Arabia, Lebanon, France, Germany,
England, USA, Belgium, Spain, India, etc. First we introduced the concept, then we lined up the
money, and finally we are leveling the playing field by sharing our library resources with the medical industry.
The alternative is to contact Chairman Natto at kalnatto2000@yahoo.com for the textbook & chapters.
Photos of West African Pharmacist in April of 2004
Click on the Visa / Mastercard Button ABOVE to Buy The Photo package of the West African Promotional Campaign
===================================================================
Disclaimer of Warranty and Limitation of Liability The information,
products and services on this web site or letter are provided on an "AS IS," "WHERE IS" and "WHERE AVAILABLE" basis.
The KIN Consortium does not warrant the information or services provided herein or your use of this
web site generally, either expressly or impliedly, for any particular purpose and expressly disclaims any implied warranties,
including but not limited to, warranties of title, non-infringement, merchantability or fitness for a particular purpose.
The KIN Consortium will not be responsible for any loss or damage that could result from interception
by third parties of any information or services made available to you via this web site. Although the information provided
to you on this web site is obtained or compiled from sources we believe to be reliable, The KIN Consortium
cannot and does not guarantee the accuracy, validity, timeliness or completeness of any information or data made available
to you for any particular purpose. Neither The KIN Consortium , nor any of its affiliates, directors,
officers or employees, nor any third party vendor, will be liable or have any responsibility of any kind for any loss or damage
that you incur in the event of any failure or interruption of this web site, or resulting from the act or omission of any
other party involved in making this web site, the data contained herein or the products or services offered on this web site
available to you, or from any other cause relating to your access to, inability to access, or use of the web site or these
materials, whether or not the circumstances giving rise to such cause may have been within the control of The KIN
Consortium or of any vendor providing software or services. In no event will The KIN Consortium
or any such parties be liable to you, whether in contract or tort, for any direct, special, indirect, consequential or incidental
damages or any other damages of any kind even if The KIN Consortium or any other such party has been
advised of the possibility thereof. This limitation on liability includes, but is not limited to, the transmission of any
viruses which may infect a user's equipment, failure of mechanical or electronic equipment or communication lines, telephone
or other interconnect problems (e.g., you cannot access your internet service provider), unauthorized access, theft, operator
errors, strikes or other labor problems. The KIN Consortium cannot and does not guarantee continuous,
uninterrupted or secure access to the web site.
Proprietary Rights All right, title and interest
in this web site and any content contained herein is the exclusive property of The KIN Consortium ,
except as otherwise stated. Unless otherwise specified, this web site is for your personal and non-commercial use only and
you may print, copy and download any information or portion of this web site for your personal use only. You may not modify,
copy, distribute, transmit, display, perform, reproduce, publish, license, frame, create derivative works from, transfer,
or otherwise use in any other way for commercial or public purposes in whole or in part any information, software, products
or services obtained from this web site, except for the purposes expressly provided herein, without The KIN Consortium's prior
written approval. If you copy or download any information or software from this web site, you agree that you will not remove
or obscure any copyright or other notices or legends contained in any such information.
The KIN Consortium and
other trademarks and service marks referenced herein are trademarks and service marks of The KIN Consortium .
The names of other companies and third-party products or services mentioned herein may be the trademarks or service marks
of their respective owners. You are prohibited from using any marks for any purpose including, but not limited to use as metatags
on other pages or sites on the World Wide Web without the written permission of The KIN Consortium
or such third party, which may own the marks.
Pursuant to Section 512(c)(2) of the Copyright Act, The KIN
Consortium designates the following agent to receive notifications of claimed infringement: Khalid I Natto,
The KIN Consortium , Email: kalnatto2000@yahoo.com, Website: http://khalidnatto.tripod.com
Use of Links This web site contains links
to third party web sites. These links are provided only as a convenience. The inclusion of any link is not and does not imply
an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by The KIN Consortium
of any information contained in any third party web site. In no event shall The KIN Consortium be responsible
for the information contained on that site or your use of or inability to use such site. You should also be aware that the
terms and conditions of such site and the site's privacy policy may be different from those applicable to your use of this
web site.